Boston Scientific Suit Says J&J’s Cypher Infringes Patent, Asks For Injunction

Opposing patent infringement claims by Boston Scientific and Johnson & Johnson introduce a level of uncertainty as to which firm will initially capture the lion's share of the U.S. drug-eluting stent market